Skip to main content
Livermore
Livermore
ZHEN

First Trust Advisors LP

SEC CIK
0001125816
Latest filing
Aug 11, 2026

PTCT holding history

PTC Therapeutics, Inc. in every 13F filed by First Trust Advisors LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

PTCT overviewAll 13F holders of PTCTFull Q2 2026 holdings

Shares (Q2 2026)
113,354
Value
$9.25M
% of portfolio
<0.1%
Quarters held
19
Since Q1 2021
Holdings of PTCT by First Trust Advisors LP, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026113,354$9.25M<0.1%−22,649−16.7%ReducedHolders
Q1 2026136,003$9.27M<0.1%−19,593−12.6%ReducedHolders
Q4 2025155,596$11.8M<0.1%+33,741+27.7%AddedHolders
Q3 2025121,855$7.48M<0.1%−3,467−2.8%ReducedHolders
Q2 2025125,322$6.12M<0.1%−16,426−11.6%ReducedHolders
Q1 2025141,748$7.22M<0.1%+7,985+6.0%AddedHolders
Q4 2024133,763$6.04M<0.1%+25,881+24.0%AddedHolders
Q3 2024107,882$4.00M<0.1%+29,283+37.3%AddedHolders
Q2 202478,599$2.40M<0.1%−1,356,881−94.5%ReducedHolders
Q1 20241,435,480$41.8M<0.1%+1,435,480NewHolders
Q4 20230$00.0%−30,539−100.0%Sold outHolders
Q3 202330,539$684.4K<0.1%−21,279−41.1%ReducedHolders
Q2 202351,818$2.11M<0.1%+19,376+59.7%AddedHolders
Q1 202332,442$1.57M<0.1%−42,921−57.0%ReducedHolders
Q4 202275,363$2.88M<0.1%−20,476−21.4%ReducedHolders
Q3 202295,839$4.81M<0.1%+37,437+64.1%AddedHolders
Q2 202258,402$2.34M<0.1%+22,523+62.8%AddedHolders
Q1 202235,879$1.34M<0.1%+22,378+165.8%AddedHolders
Q4 202113,501$538.0K<0.1%+13,501NewHolders
Q2 20210$00.0%−55,740−100.0%Sold outHolders
Q1 202155,740$2.64M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.